IMAX Form 4: Officer sells 49,504 shares after option exercise

IMAX (IMAX) executive Mark Welton reported an option exercise and share sale.

Rhea-AI Filing Summary

IMAX (IMAX) executive Mark Welton reported an option exercise and share sale. On 11/10/2025, he exercised stock options into 49,504 common shares at $22.49 per share and sold 49,504 common shares at a price of $35.228.

Following these transactions, he beneficially owns 153,323 common shares directly. The filing notes 70,609 restricted share units outstanding after these transactions and that the options exercised were issued in 2019 and set to expire on March 7, 2026.

Insider Trade Summary

Exercise and Sale: 49,504 shares ($631K approx. pre-tax spread)

Exercise and Sale 4 txns

Insider WELTON MARK

Role President IMAX Global Theatres

Sold 49,504 shs ($1.74M)

Approx. gross sale proceeds $1.74M

Approx. exercise cost $1.11M

Approx. pre-tax spread $631K

Type	Security	Shares	Price	Value
Conversion	stock options (to buy)	49,504	$22.49	$1.11M
Conversion	common shares	49,504	$22.49	$1.11M
Sale	common shares	49,504	$35.228	$1.74M
holding	common shares (opening balance)	--	--	--

Holdings After Transaction: stock options (to buy) — 0 contracts (Direct); common shares — 153,323 shares (Direct); common shares (opening balance) — 153,323 shares (Direct)

Footnotes (4)

1. F1. Represents the conversion upon exercise of stock options into common shares.
2. F2. These options were issued in 2019 and are set to expire on March 7, 2026.
3. F3. The stock options became exercisable in four installments: 9,900 on March 7, 2020, 12,376 on each of March 7, 2021 and March 7, 2022 and 14,852 on March 7, 2023.
4. F4. Mr. Welton's aggregate remaining outstanding restricted share unit and common share balances following these transactions will be 70,609 and 153,323, respectively.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did IMAX (IMAX) report on this Form 4?

Officer Mark Welton reported exercising options into 49,504 common shares at $22.49 and selling 49,504 shares at $35.228 on 11/10/2025.

How many IMAX shares does Mark Welton hold after the transactions?

He beneficially owns 153,323 common shares directly after the reported transactions.

How many restricted share units (RSUs) remain for Mark Welton?

The filing notes 70,609 RSUs outstanding following these transactions.

What was the source of the shares sold by Mark Welton?

They were acquired via the conversion upon exercise of stock options into common shares.

What were the exercise and sale prices reported?

Exercise price was $22.49 per share; sale price was $35.228 per share.

When do the exercised options expire and when were they issued?

They were issued in 2019 and set to expire on March 7, 2026.

What is Mark Welton’s role at IMAX?

He is President, IMAX Global Theatres.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/10/2025 - 08:28 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WELTON MARK

(Last) (First) (Middle)

2525 SPEAKMAN DRIVE

C/O IMAX CORPORATION

(Street)

MISSISSAUGA A6 L5K 1B1

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President IMAX Global Theatres

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
common shares (opening balance)								153,323	D
common shares	11/10/2025		C		49,504(1)	A	$22.49	202,827	D
common shares	11/10/2025		S		49,504	D	$35.228	153,323	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock options (to buy)(2)	$22.49	11/10/2025		C			49,504	(3)	03/07/2026	common shares	49,504	$22.49	0(4)	D

Explanation of Responses:

1. Represents the conversion upon exercise of stock options into common shares.

2. These options were issued in 2019 and are set to expire on March 7, 2026.

3. The stock options became exercisable in four installments: 9,900 on March 7, 2020, 12,376 on each of March 7, 2021 and March 7, 2022 and 14,852 on March 7, 2023.

4. Mr. Welton's aggregate remaining outstanding restricted share unit and common share balances following these transactions will be 70,609 and 153,323, respectively.

	/s/ Kenneth I. Weissman (attorney-in-fact for Mark Welton)	11/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.